# Nuclide record myelosuppression-after-rlt (term). Data CC BY-NC 4.0, attribute "Data from Nuclide (nuclide.cc)". Whole corpus: https://nuclide.cc/api/v1/nuclide.nt
@prefix schema: <https://schema.org/> .
@prefix nuclide: <https://nuclide.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://nuclide.cc/terms/myelosuppression-after-rlt/>
  a schema:DefinedTerm ;
  nuclide:kind "term" ;
  schema:identifier "myelosuppression-after-rlt" ;
  schema:name "Myelosuppression after radioligand therapy"@en ;
  schema:description "Radioactive cancer treatments that circulate through the blood also irradiate bone marrow, so blood counts (red cells, white cells, platelets) can drop. Doctors check blood counts regularly and pause or reduce treatment if counts fall too far."@en ;
  schema:url <https://nuclide.cc/terms/myelosuppression-after-rlt/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/215833s021s024lbl.pdf>, <https://www.novartis.com/us-en/sites/novartis_us/files/pluvicto.pdf>, <https://jnm.snmjournals.org/content/65/11/1740> ;
  nuclide:tag "adverse effect", "haematology", "radioligand therapy" ;
  nuclide:related <https://nuclide.cc/drugs/pluvicto/>, <https://nuclide.cc/trials/vision/>, <https://nuclide.cc/trials/psmafore/>, <https://nuclide.cc/terms/cytopenias/>, <https://nuclide.cc/terms/thrombocytopenia/>, <https://nuclide.cc/terms/anaemia/>, <https://nuclide.cc/terms/bone-marrow/>, <https://nuclide.cc/technologies/prrt/>, <https://nuclide.cc/drugs/lutathera/>, <https://nuclide.cc/isotopes/lu-177/>, <https://nuclide.cc/isotopes/y-90/> .